Skip to content

Clinical trials

Essential Hypertension trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Country / region: Japan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20051
20061
20073
20103
20114
20123
20141
20151
20163

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Daiichi Sankyo Co., Ltd.4
Bayer3
Kyoto University2
Novartis2
Yokohama City University Medical Center2
Daiichi Sankyo1
Seiji Umemoto, M.D., Ph.D.1
Takeda1
Tokyo University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension24
Hypertension12
Diabetes Mellitus2
Renal Insufficiency2
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Diabetic Nephropathies1

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.